(S (NP-SBJ The/DT c-rel/NN protooncogene/NN product/NN) (VP represses/VBZ (NP (NP (ADJP NF-kappa/NN B/NN p65-mediated/JJ) transcriptional/JJ activation/NN) (PP of/IN (NP (NP the/DT long/JJ terminal/JJ repeat/NN) (PP of/IN (NP type/NN 1/CD human/JJ immunodeficiency/NN virus/NN)))))) ./.)
(S (NP-SBJ-COOD (NP (NP (NP The/DT long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-)) (PP of/IN (NP (NP the/DT type/NN 1/CD human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV-1/NN) -RRB-/-RRB-)))) and/CC (NP (NP the/DT 5'/JJ regulatory/JJ region/NN) (PP of/IN (NP (NP the/DT gene/NN) (VP encoding/VBG (NP (NP the/DT interleukin/NN 2/CD receptor/NN alpha/NN subunit/NN) (PRN -LRB-/-LRB- (NP IL-2R/NN alpha/NN) -RRB-/-RRB-))))))) (VP share/NN (NP (NP functional/JJ kappa/NN B/NN enhancer/NN elements/NNS) (VP involved/VBN (NP */-NONE-) (PP in/IN (NP (NP the/DT regulation/NN) (PP of/IN (NP these/DT inducible/JJ transcription/NN units/NNS)) (PP-TMP during/IN (NP T-cell/NN activation/NN))))))) ./.)
(S (NP-SBJ-56 These/DT kappa/NN B/NN enhancer/NN elements/NNS) (VP are/VBP (VP recognized/VBN (NP *-56/-NONE-) (PP by/IN (NP (NP a/DT (ADJP structurally/RB related/JJ) family/NN) (PP of/IN (NP interactive/JJ proteins/NNS)) (SBAR (WHNP-57 that/WDT) (S (NP-SBJ *T*-57/-NONE-) (VP includes/VBZ (NP-COOD (NP p50/NN) ,/, (NP p65/NN) ,/, and/CC (NP (NP (NP the/DT product/NN) (PP of/IN (NP the/DT c-rel/NN protooncogene/NN))) (PRN -LRB-/-LRB- (NP c-Rel/NN) -RRB-/-RRB-)))))))))) ./.)
(S (NP-SBJ Recent/JJ biochemical/JJ studies/NNS) (VP have/VBP (VP shown/VBN (SBAR that/IN (S (NP-SBJ-COOD (NP p65/NN) and/CC (NP p50/NN)) (VP form/VBP (NP (NP the/DT prototypical/JJ NF-kappa/NN B/NN complex/NN) ,/, (SBAR (WHNP-58 which/WDT) (S (NP-SBJ-59 *T*-58/-NONE-) (VP is/VBZ (VP (ADVP-TMP rapidly/RB) translocated/VBN (NP *-59/-NONE-) (PP from/IN (NP the/DT cytoplasm/NN)) (PP to/TO (NP the/DT nucleus/NN)) (PP-TMP during/IN (NP T-cell/NN activation/NN)))))))))))) ./.)
(S (NP-SBJ This/DT intracellular/JJ signaling/NN complex/NN) (ADVP potently/RB) (VP stimulates/VBZ (NP (NP (ADJP kappa/NN B-directed/JJ) transcription/NN) (PP from/IN (NP-COOD either/CC (NP the/DT HIV-1/NN LTR/NN) or/CC (NP the/DT IL-2R/NN alpha/NN promoter/NN)))) (PP via/IN (NP (NP the/DT strong/JJ transactivation/NN domain/NN) (ADJP present/JJ (PP in/IN (NP p65/NN)))))) ./.)
(S (NP-SBJ We/PRP) (ADVP-TMP now/RB) (VP demonstrate/VBP (SBAR that/IN (S (NP-SBJ (NP nuclear/JJ expression/NN) (PP of/IN (NP human/JJ c-Rel/NN)) ,/, (SBAR (WHNP-60 which/WDT) (S (NP-SBJ-61 *T*-60/-NONE-) (VP is/VBZ (VP induced/VBN (NP *-61/-NONE-) (PP by/IN (NP-COOD either/DT (NP phorbol/NN ester/NN) or/CC (NP tumor/NN necrosis/NN factor/NN alpha/NN))) (PP with/IN (NP (NP delayed/VBN kinetics/NNS) (ADJP relative/JJ (PP to/TO (NP p65/NN))))))))) ,/,) (ADVP markedly/RB) (VP represses/VBZ (NP (NP p65-mediated/JJ activation/NN) (PP of/IN (NP these/DT transcription/NN units/NNS))))))) ./.)
(S (NP-SBJ (NP These/DT inhibitory/JJ effects/NNS) (PP of/IN (NP c-Rel/NN))) (VP correlate/VBP (PP-COOD (PP with/IN (NP its/PRP$ DNA-binding/JJ activity/NN)) but/CC (PP not/RB with/IN (NP its/PRP$ ability/NN (S (NP-SBJ */-NONE-) (VP to/TO (VP heterodimerize/VB (PP with/IN (NP p50/NN)))))))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ c-Rel/NN inhibition/NN) (VP involves/VBZ (NP (NP competition/NN) (PP with/IN (NP p50\/p65/NN)) (PP for/IN (NP (NP occupancy/NN) (PP of/IN (NP the/DT kappa/NN B/NN enhancer/NN element/NN))))))))))) ./.)
(S (ADVP Together/RB) ,/, (NP-SBJ these/DT findings/NNS) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ (NP one/CD function/NN) (PP of/IN (NP c-Rel/NN))) (VP is/VBZ (S-PRD (PP as/IN (NP (NP a/DT physiologic/JJ repressor/NN) (PP of/IN (NP the/DT (NP-COOD (NP HIV-1/NN LTR/NN) and/CC (NP IL-2R/NN alpha/NN)) promoters/NNS)))) ,/, (NP-SBJ-64 */-NONE-) (VP serving/VBG (S (NP-SBJ *-64/-NONE-) (VP to/TO (VP (ADVP efficiently/RB) counter/VB (NP (NP the/DT strong/JJ transcriptional/JJ activating/JJ effects/NNS) (PP of/IN (NP p65/NN)))))))))))) ./.)
